Abstract
Although it seems reasonable to suggest that most women experience significant changes in quality of life (QOL) during the menopausal period, few researchers have quantified these changes. A total of 1497 women, aged 40–54 years and living on the island of Kinmen, were recruited for this survey. However, 137 were eliminated leaving 1360 for analysis. Women who used hormonal therapy or who had undergone surgically induced menopause were excluded. The subjects with incomplete data or who exhibited mental retardation or severe psychiatric disease were also eliminated. Univariate analysis demonstrated that, in general, QOL scores were poorer for perimenopausal and postmenopausal status. Comparing pre- and postmenopausal women, significant statistical differences were demonstrated for role limitations due to physical and emotional problems, even after adjusting for age, education level, body mass index, menarche, and chronic illness. A strong association was demonstrated between menopausal symptoms and premens-trual syndrome (PMS). Women with menopausal symptoms and PMS had significantly lower scores on all SF-36 dimensions. The results of this study suggest that poorer health status is experienced by peri- and postmenopausal women compared to premenopausal women.
Similar content being viewed by others
References
Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. Br Med J 1993; 307: 836–840.
Ledesert B, Ringa V, Breart G. Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 1994; 20: 113–120.
Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: A population study. Maturitas 2000; 34: 17–23.
Derman RJ, Dawood MY, Stone S. Quality of life during sequential hormone replacement therapy-a placebo-controlled study. Int J Fertil 1995; 40: 73–78.
Wklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168: 824–830.
Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Pors Nielsen S. Combined versus sequential hormonal replacement therapy: A double-blind, placebo-controlled study on quality of life-related outcome measures. Psychother Psychosom 1998; 67: 259–265.
Karlberg J, Mattsson LA, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995; 74: 367–372.
Kaufert P, Lock M, McKinlay S, et al. Menopause research: the Kofole limitation due to physical problemsilampi workshop. Soc Sci Med 1986; 22: 1285–1289.
Tang GWK. The climacteric of Chinese factory workers. Maturitas 1994; 17: 177–182.
Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven southeast Asian countries. Maturitas 1994; 19: 157–176.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey-Manual and Intefole limitation due to physical problemsretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: A validation study. J Epidemiol Commun Health 1980; 64: 281–286.
Fuh JL, Wang SJ, Lu SR, Juang, Lee SJ. Psychometric evaluation of a Chinese (Taiwanese) version of the SF-36 Health Survey amongst Middle Aged Women from a Rural Community. Qual Life Res 2000; 9: 675–683.
Fuh JL, Wang SJ, Lu SR, Juang KD, Chiu LM. The Kinmen women-health investigation (KIWI): A menopausal study of a population aged 40-54. Maturitas 2001; 39: 117–124.
Ware JE, Keller SD, Gandek B, Brazier JE, Sullivan M. Evaluating translations of health status questionnaire: Methods from the IQOLA Project. Int J Technol Assess Health Care 1995; 11: 525–551.
Zigmond AS, Smaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
Juang KD, Wang SJ, Juang KD, Wang SJ, Lin CH, Fuh JL. Use of the hospital anxiety and depression scale as a screening tool for patients with headache. Chin Med J (Taipei) 1999; 62: 749–755.
Blatt MHG, Wiesbader H, Kupperman HS. Vitamin E and climacteric syndrome: Failure of effective control as measured by menopausal index. Arch Intern Med 1953; 91: 792–799.
World Health Organization. Mental, behavioral and developmental disorders. In: Tenth Revision of the International Classification of Disease (ICD-10). Geneva: World Health Organization, 1996.
Kessel B. Premenstrual syndrome: Advances in diagnosis and treatment. Obstet Gynecol Clin North Am 2000; 27: 625–639.
Lam CL, Pan PC, Chen AW, Chan SY, Munro C. Can the hospital anxiety and depression (HAD) scale be used on Chinese elderly in general practice? Family Pract 1995; 12: 149–154.
Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 1995; 123: 673–675.
Poehlman ET, Goran MI, Gardner AW, et al. Determinants of the decline in resting metabolic rate in aging females. Am J Physiol 1993; 264: E450–E455.
Sowers MF, Pope S, Welch G, Sternfeld B, Albrecht G. The association of menopause and physical functioning in women at midlife. J Am Geriatr Soc 2001; 49: 1485–1492.
Cooph J, Hunter M. Impact of menopausal symptoms: Effect on quality of life exaggerated. Br Med J 1993; 307: 1420–1421.
Ballinger CB. Psychiatric morbidity and the menopause: Screening of a general population sample. Br Med J 1975; 3: 344–346.
Dennerstein L, Smith AMA, Morse C. Psychological well-being, mid-life and the menopause. Maturitas 1994; 20: 1–11.
Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episodes with menopausal hot flashes. JAMA 1981; 245: 1741–1744.
Gonen R, Sharf M, Lavie P. The association between mid sleep waking episodes and hot flashes in post-menopausal women. J Psychosom Obstet Gynaecol 1986; 5: 113–115.
Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep 1988; 11: 556–561.
Holte A. Influences of natural menopause on health complaints: A prospective study of healthy Norwegian women. Maturitas 1992; 14: 127–141.
Collins A, Landgren BM. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: A population-based study. Maturitas 1995; 20: 101–111.
Bancroft J, Backstrom T. Premenstrual syndrome. Clin Endocrinol 1985; 22: 313–336.
Woods NF, Mitchell ES, Lentz MJ. Social pathways to premenstrual symptoms. Res Nursing Health 1995; 18: 225–237.
Woods NF, Lentz MJ, Mitchell ES, Shaver J, Heitkemper M. Luteal phase ovarian steroids, stress arousal, premenses, perceived stress, and premenstrual symptoms. Res Nursing Health 1998; 21: 129–142.
Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994; 19: 157–176.
Chen YD, Voda AM, Mansfield PK. Chinese midlife women's perceptions and attitudes about menopause. Menopause 1998; 5: 28–34.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuh, JL., Wang, SJ., Lee, SJ. et al. Quality of life and menopausal transition for middle-aged women on Kinmen island. Qual Life Res 12, 53–61 (2003). https://doi.org/10.1023/A:1022074602928
Issue Date:
DOI: https://doi.org/10.1023/A:1022074602928